Brief: Bluejay Diagnostics Reports Q3 Loss Per Share Of $0.11
16/12/2021 14:37
Dec 16 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS, INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS
* Q3 LOSS PER SHARE $0.11
* EXPANDED TESTING PROGRAM PLANNED FOR Q1-Q3 2022
Source text for Eikon: ID:nGNX5GPkfF
Further company coverage: BJDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook